Investing.com -- 全球临床研究机构Icon plc (NASDAQ:ICLR)在发布超出分析师预期的第二季度财报并上调全年指引后,盘后交易中股价飙升14.6%。 这家总部位于都柏林的公司报告第二季度调整后每股摊薄收益为$3.26,超过分析师预估的$3.19。营收达到$2.02亿,高于市场一致预期的$1.98亿,不过与去年同期相比下降了4.8%。 Icon上调了2025财年的营收指引...
Source LinkInvesting.com -- 全球临床研究机构Icon plc (NASDAQ:ICLR)在发布超出分析师预期的第二季度财报并上调全年指引后,盘后交易中股价飙升14.6%。 这家总部位于都柏林的公司报告第二季度调整后每股摊薄收益为$3.26,超过分析师预估的$3.19。营收达到$2.02亿,高于市场一致预期的$1.98亿,不过与去年同期相比下降了4.8%。 Icon上调了2025财年的营收指引...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.